Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Zimmer to Sell Notes – Analyst Blog

Zacks Market Commentaries (November 13th, 2009) Writes:
Zimmer Holdings, Inc. (ZMH) recently decided to raise $1 billion by selling its senior unsecured notes in an underwritten public offering in two separate transactions. The transactions involve selling $500.0 million of 4.625% notes due 2019 and $500.0 million of 5.75% notes due 2039. The public offering is expected to close on Nov 17, 2009.   Zimmer has already filed an automatic shelf registration statement on Form S-3 with the Securities and Exchange Commission for the public offer. Citigroup Global Markets Inc., a division of Citigroup, Inc. (C); Banc of America Securities LLC, a division of Bank of America Corp. (BAC); and J.P. Morgan Securities Inc., a division of JPMorgan Chase & Co. (JPM) are the active joint book-running managers of the offering. The offer will be made to the public through the prospectus.   The 2019 notes yield 118 basis points above the Treasury ...

Zacks Analyst Blog Highlights: Stryker Corp., Synergetics USA, Inc., Zimmer Holdings, Conmed Corporation and Smith & Nephew – Press Releases

Zacks Market Commentaries (November 13th, 2009) Writes:

For Immediate Release

Chicago, IL – November 13, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Stryker Corp. (SYK), Synergetics USA, Inc. (SURG), Zimmer Holdings (ZMH), Conmed Corporation (CNMD) and Smith & Nephew (SNN).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Thursday’s Analyst Blog:

Stryker Strikes Acquisition Deals

Stryker Corp. (SYK) is on a takeover spree having made three acquisitions recently. The company acquired OtisMed Corp., Mutoh Co. Ltd. and certain of its affiliates, and Synergetics USA, Inc. (SURG). Financial terms of these transactions include $67 million

...

Stryker Strikes Acquisition Deals – Analyst Blog

Zacks Market Commentaries (November 12th, 2009) Writes:

Stryker Corp. (SYK) is on a takeover spree having made three acquisitions recently. The company acquired OtisMed Corp., Mutoh Co. Ltd. and certain of its affiliates, and Synergetics USA, Inc. (SURG). Financial terms of these transactions include $67 million in upfront payment as well as potential future milestone and royalty payments of up to $36 million. These acquisitions are expected to be completed by the end of 2009.

OtisMed Corp. is a privately held software technology firm that focuses on customizable instrumentation complementing Stryker’s Triathlon Knee System, as well as other Stryker implants. Stryker will incorporate OtisMed as part of its Orthopaedics division. Mutoh Co. Ltd. is a Japanese company and a leading provider of equipment, products, instruments and services to the medical and scientific communities. On the other hand, Synergetics USA, Inc. is a leading supplier of precision microsurgery instrumentation.   Mutoh and Synergetics acquisitions give Stryker access to

...

Conmed Surpasses Zacks Estimate – Analyst Blog

Zacks Market Commentaries (October 27th, 2009) Writes:
Conmed Corporation (CNMD) reported third quarter 2009 earnings per share of 28 cents, surpassing the Zacks Consensus Estimate of 17 cents. However, earnings per share were lower than the year-ago earnings of 37 cents. Sales Net sales for the reported quarter were $175.5 million, declining roughly 2.2% year over year. Excluding an unfavorable foreign currency translation (FX), net sales increased marginally by 0.4% year over year. Single-use and reposable sales contributed roughly 75% to total sales and declined 0.4% year over year. Capital equipment sales contributed the balance and declined 7.1% year over year. The decline in net sales can be primarily attributed to the current economic turbulence that resulted in patients deferring their elective procedures. The decline was broad-based across major products. Arthroscopy sales declined 1.2% year over year to $68.7 million. Powered Surgical Instruments sales declined 3.9% year over year to $37.3 ...

Zimmer Outdoes, Reaffirms Outlook – Analyst Blog

Zacks Market Commentaries (October 23rd, 2009) Writes:
Zimmer Holdings Inc. (ZMH) today reported earnings per share of 88 cents in the third quarter of 2009, beating the Zacks Consensus Estimate of 86 cents. However, earnings per share declined by 9.3% year over year in the reported quarter.  Net Sales  Net sales in the reported quarter increased 2.4% year over year to $976 million. Excluding an unfavorable foreign currency translation (FX), net sales increased 3.6% year over year. On a geographic basis, U.S. sales represented approximately 60% of total revenues and increased 4% year over year. Europe revenues declined 3% year over year to $242 million. Asia-Pacific contributed $149 million of revenues and increased 8% year over year.  Excluding Dental, growth in net sales was witnessed across all the product categories. Reconstructive sales represented roughly 76% of total revenues and increased 1% year over year. The Spine segment registered a strong growth of 24% ...

Stryker Meets Expectations – Analyst Blog

Zacks Market Commentaries (October 21st, 2009) Writes:
Stryker Corporation (SYK) yesterday reported third quarter earnings per share of 69 cents, in line with the Zacks Consensus Estimate and higher than the year-ago earnings of 66 cents. Net sales were flat year over year at approximately $1.7 billion. An unfavorable foreign exchange translation (FX) negatively affected net sales in the quarter.  Excluding FX, net sales increased 1.2% year over year. On a geographic basis, U.S. sales contributed roughly 65% of total sales and increased 0.2% year over year. International sales declined 0.3% year over year. In terms of business segments: Orthopaedic Implants sales increased 5.5% year over year to $1.0 billion. Growth was contributed by all the products, such as Hips, Knees, Trauma, Spine, and Craniomaxillofacial.  MedSurg Equipment sales declined 7.7% year over year to $637 million. The decline can be primarily attributed to lower capital spending by hospitals due to the current economic turmoil. Gross ...

Conmed Recalls Products – Analyst Blog

Zacks Market Commentaries (September 11th, 2009) Writes:
Conmed Corporation (CNMD) has recently started the process of recalling certain products due to manufacturing defects. Products affected are PRO5 and PRO6 series battery handpieces manufactured before May 31, 2008. Also affected are certain lots of the MC5057 Universal Cable manufactured prior to Dec 1, 2006, that are used along with the company’s electric powered handpieces. All these products were manufactured by Conmed’s Linvatec unit. The company has sent letters to customers notifying about the defects and stating the process to return these products for rectification.  The PRO5 and PRO6 series battery handpieces have the risk of potential self-activating. Therefore, safe and efficient usage includes inserting the battery away from the operation site and not touching or coming into contact with moving parts while inserting the battery.  The MC5057 Universal Cable has the risk of an electric powered handpiece to potentially self-activate. Here the safe and ...

Conmed Tops, Lowers Outlook – Analyst Blog

Zacks Market Commentaries (July 31st, 2009) Writes:
Conmed Corporation (CNMD) reported its second quarter results yesterday and lowered its outlook for the full year. GAAP EPS was $0.05, considerably lower than the year-ago EPS of $0.40. Non-GAAP EPS was $0.17, compared to the Zacks Consensus Estimate of $0.16 and the year-ago EPS of $0.43.   Sales   Net sales in the quarter were $164.6 million, declining roughly 15% year over year. The decline in net sales can be attributed to adverse foreign exchange rate fluctuations (FX) and economic turbulence leading hospitals to delay purchasing capital equipments. Excluding FX, net sales declined roughly 10% year over year.   All the business segments reported lower sales. In terms of the top three business segments: Arthroscopy sales declined roughly 20% year over year to $61.6 million. Powered Surgical Instruments sales declined roughly 16% year over year to $33.5 million. Electrosurgery sales declined 12% year over year to $22.7 ...

Zimmer Exceeds Street Expectations – Analyst Blog

Zacks Market Commentaries (July 24th, 2009) Writes:
Zimmer Holdings, Inc. (ZMH) reported second quarter of 2009 results with EPS exceeding the street estimates. EPS was $0.98, compared to $0.99 in the year-ago quarter but higher than the street expectations of $0.96 (Source: Reuters estimates). Adjusted EPS was $1.00, compared to $1.03 in the year-ago quarter.  Net sales for the quarter were $1.02 billion, a decline of roughly 5.5% year over year but above the street expectation of $1.01 billion (Source: Reuters estimates). The company attributed the year over year decline in net sales to an unfavorable impact from foreign exchange translation (FX). We believe lower sales volume resulting from customer losses due to the current economic turbulence also contributed to the declining sales. Excluding FX, net sales declined only 0.6% year over year.  During the quarter, all geographic regions showed a decline in sales, with the largest in Europe. Average Selling Prices (ASPs) ...

Stryker’s Q2 Results Disappoint – Analyst Blog

Zacks Market Commentaries (July 22nd, 2009) Writes:

Stryker Corporation (SYK), one of the world’s largest medical device companies operating in the global orthopedic market, reported its financial results for the second quarter of fiscal 2009. Net sales in the quarter were $1,634.3 million, a decline of 4.6% year over year. The company was hurt by a slowdown in MedSurg businesses and foreign currency (FX) headwinds. Excluding FX, net sales were roughly flat, compared to last year.

In terms of business segments: Orthopaedic Implants sales were roughly flat year over year at $1,014.2 million. The company witnessed strong U.S. sales buoyed by higher shipments of reconstructive, trauma, spinal and craniomaxillofacial implant systems. However, international sales were lower due to currency headwinds. MedSurg Equipment sales declined 11% year over year to $620.1 million. This segment was hurt by the global economic slowdown with patients delaying their surgical operations. Lower shipments of surgical equipment and surgical navigation systems, endoscopic, communications

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.